Decoy Therapeutics Inc Asset Turnover Ratio (DCOY), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Decoy Therapeutics Inc   (DCOY)
 

Decoy Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Decoy Therapeutics Inc asset turnover ratio, the ability of Decoy Therapeutics Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.01 in the second quarter (Jun 30 2026), DCOY's balance sheet remain strong.

Within sector Decoy Therapeutics Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DCOY Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 750.06 % 260.06 % 1084.67 % 57.99 % -60.81 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.01 - - - -
DCOY's Total Ranking # # # # #
Seq. Asset Change 40.56 % -76.48 % 487.36 % 337.77 % -40.46 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




DCOY Company Profile • Back to DCOY Efficiency Comparisons • Compare DCOY Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Prophase Labs Inc   0.05 $ 3.150  Millions$ 60.428  Millions
Insight Molecular Diagnostics Inc   0.05 $ 1.670  Millions$ 34.891  Millions
Dar Bioscience Inc   0.05 $ 1.345  Millions$ 28.355  Millions
Nakamoto Inc   0.05 $ 28.962  Millions$ 616.576  Millions
Agape Atp Corporation  0.05 $ 1.152  Millions$ 24.729  Millions
Instil Bio Inc   0.04 $ 8.968  Millions$ 203.358  Millions
Camp4 Therapeutics Corporation  0.04 $ 4.216  Millions$ 100.772  Millions
Vistagen Therapeutics Inc   0.04 $ 2.501  Millions$ 62.393  Millions
Kyntra Bio Inc   0.04 $ 4.617  Millions$ 116.829  Millions
Blue Water Vaccines Inc  0.03 $ 0.646  Millions$ 18.966  Millions
Northwest Biotherapeutics Inc  0.03 $ 2.173  Millions$ 66.973  Millions
Tao Synergies Inc   0.03 $ 0.772  Millions$ 24.086  Millions
Atrium Therapeutics Inc   0.03 $ 35.974  Millions$ 1,166.283  Millions
Co diagnostics Inc   0.03 $ 0.721  Millions$ 26.893  Millions
Dbv Technologies S a   0.02 $ 5.018  Millions$ 223.351  Millions
Fate Therapeutics Inc   0.02 $ 6.491  Millions$ 301.907  Millions
Medicinova Inc   0.02 $ 0.920  Millions$ 44.080  Millions
Mangoceuticals Inc   0.02 $ 0.315  Millions$ 15.311  Millions
Bioxcel Therapeutics Inc   0.02 $ 0.742  Millions$ 38.133  Millions
Hyperion Defi inc   0.02 $ 1.401  Millions$ 79.440  Millions
Aspire Biopharma Holdings Inc   0.02 $ 0.103  Millions$ 6.093  Millions
Alumis inc   0.01 $ 7.398  Millions$ 533.040  Millions
Vyne Therapeutics Inc   0.01 $ 0.430  Millions$ 31.089  Millions
Vivosim Labs Inc   0.01 $ 0.112  Millions$ 8.892  Millions
Envoy Medical Inc   0.01 $ 0.207  Millions$ 17.628  Millions
Bellevue Life Sciences Acquisition Corp  0.01 $ 1.809  Millions$ 171.835  Millions
Cardiff Oncology Inc   0.01 $ 0.508  Millions$ 53.041  Millions
Sharps Technology Inc   0.01 $ 2.468  Millions$ 263.597  Millions
Clene Inc   0.01 $ 0.197  Millions$ 21.287  Millions
Scienture Holdings Inc   0.01 $ 0.821  Millions$ 89.351  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.